Britain on Wednesday became the first country in the world to approve the Pfizer-BioNTech Covid-19 vaccine for use and said that it will be rolled out from early next week.
“The Government has today accepted the recommendation from the independent Medicines and Healthcare products Regulatory Agency (MHRA) to approve Pfizer-BioNTech’s Covid-19 vaccine for use,” the government said.
“The vaccine will be made available across the UK from next week.”
Pfizer said Britain's emergency use authorisation marks a historic moment in the fight against Covid-19.
Covid-19: Time for Government to reassess strategy for tackling pandemic
‘Rapid acceleration’ in Covid-19 insolvencies awaits tourism sector
Miriam Lord: Taoiseach's task force on vaccination fails to stem repeated jabs from Kelly
‘Contradiction’ of allowing cinemas but not theatres to reopen is raised in Seanad
"This authorisation is a goal we have been working toward since we first declared that science will win, and we applaud the MHRA for their ability to conduct a careful assessment and take timely action to help protect the people of the UK," said CEO Albert Bourla.
“As we anticipate further authorisations and approvals, we are focused on moving with the same level of urgency to safely supply a high-quality vaccine around the world.”
Health Secretary Matt Hancock said the programme would begin early next week. Hospitals, he said, were already ready to receive it.
“It is very good news,” Mr Hancock said.
Britain’s vaccine committee will decide which priority groups will get the jab first such as care home residents, health and care staff, the elderly and people who are clinically extremely vulnerable. Both
Pfizer-BioNTech and US biotech firm Moderna have reported preliminary findings of more than 90 per cent effectiveness - an unexpectedly high rate - in trials of their vaccines, which are both based on new messenger RNA (mRNA) technology.– Reuters
